Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Baxter International (BAX – Research Report), Mersana Therapeutics (MRSN – Research Report) and Acadia Healthcare (ACHC – Research Report).
Baxter International (BAX)
Citi analyst Joanne Wuensch maintained a Hold rating on Baxter International yesterday and set a price target of $47.00. The company’s shares closed last Thursday at $45.48.
According to TipRanks.com, Wuensch is a 5-star analyst with an average return of
Currently, the analyst consensus on Baxter International is a Moderate Buy with an average price target of $51.67, implying a 9.4% upside from current levels. In a report issued on July 19, Bank of America Securities also maintained a Hold rating on the stock with a $48.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Mersana Therapeutics (MRSN)
According to TipRanks.com, Mubarack is ranked #7042 out of 8533 analysts.
Mersana Therapeutics has an analyst consensus of Hold, with a price target consensus of $2.25, representing a 132.4% upside. In a report released yesterday, Truist Financial also downgraded the stock to Hold with a $5.00 price target.
Acadia Healthcare (ACHC)
Bank of America Securities analyst Kevin Fischbeck reiterated a Buy rating on Acadia Healthcare today and set a price target of $100.00. The company’s shares closed last Thursday at $73.36.
According to TipRanks.com, Fischbeck is a 3-star analyst with an average return of
Acadia Healthcare has an analyst consensus of Strong Buy, with a price target consensus of $95.75.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BAX:
